Michael Autieri

Michael Autieri is a Professor and Director at the Lemole Center for Integrated Lymphatics and Vascular Research, Associate Director of the Cardiovascular Research Center, and holds affiliations with the Center for Metabolic Disease Research and Sol Sherry Thrombosis Research Center at Lewis Katz School of Medicine, Temple University. He earned his PhD from Hahnemann University in Philadelphia, PA.

• Research Focus: Regulation of vascular inflammation via endogenous anti-inflammatory cytokines (e.g., IL-19), mechanisms of atherosclerosis, restenosis, allograft vasculopathy, and therapeutic angiogenesis for peripheral vascular disease.
• Key Contributions: IL-19's role in macrophage polarization, cholesterol homeostasis, endothelial/smooth muscle proliferation, and mRNA stability. Recent work includes FXR1 regulation of vascular contractility, mitochondrial fission in hypertension, and neuro-lymphatic communication via CXCL12/CXCR4.

Article Trends: Over 15 most recent publications, Autieri's work spans RNA biology (e.g., FXR1, ILF3), lymphatic-vascular crosstalk (e.g., IL-19, Prox1), metabolic-inflammatory syndromes (e.g., LDLRAP1, adipose dysfunction), and novel therapeutic targets (e.g., stress granules, chemokine signaling). His research integrates vascular biology, immunometabolism, and RNA regulatory networks to combat cardiovascular diseases.